Regenerative Biologics
Regenerative Biologics Overview
How we categorize biologic options, what the current evidence supports, and how candidacy is decided.
Biologic therapies fall into broad groups: preparations from your own tissue (autografts), donor-derived products (allografts), and signaling-focused preparations. They differ in regulatory status, preparation, and the strength of evidence behind them.
Candidacy is decided by diagnosis, stage, and goals — not by product availability. Where evidence is limited or a use is considered investigational, that is stated in writing before consent.
What to expect
- Autologous, allograft, and signaling categories
- Regulatory status disclosed for each option
- Evidence and alternatives documented
- Surgical referral when it is the better path
Related services
Programs patients most often combine with this one.
Regenerative Biologics
Autografts
Preparations made from your own tissue, processed and reintroduced during the same visit.
View Service DetailsRegenerative Biologics
Allografts
Screened donor-derived tissue products, with regulatory status and sourcing disclosed before consent.
View Service DetailsRegenerative Biologics
Exosomes
Signaling-focused preparations under active study, discussed with their investigational status stated plainly.
View Service Details